While allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potential curative therapy against hematological malignancies, modulation of donor T cell alloreactivity is required to enhance the graft-versus-leukemia (GVL) effect and control graft-versus-host-disease (GVHD) after allo-HSCT. Donor-derived regulatory CD4CD25Foxp3 T cells (Tregs) play a central role in establishing of immune tolerance after allo-HSCT. They could be a key target to be modulated for increasing the GVL effect and control of GVHD. We constructed an ordinary differential equation model incorporating bidirectional interactions between Tregs and effector CD4 T cells (Teffs) as a mechanism for control of Treg cell concentration. The goal is to elucidate how the interaction between Tregs and Teffs is modulated in order to get insights into fine tuning of alloreactivity after allo-HSCT. The model was calibrated with respect to published Treg and Teff recovery data after allo-HSCT. The calibrated model exhibits perfect or near-perfect adaptation to stepwise perturbations between Treg and Teff interactions, as seen in Treg cell populations when patients with relapsed malignancy were treated with anti-CTLA-4 (cytotoxic T lymphocyte-associated antigen 4). In addition, the model predicts observed shifts of Tregs and Teffs concentrations after co-stimulatory receptor IL-2R or TNFR2 blockade with allo-HSCT. The present results suggest simultaneous blockades of co-stimulatory and co-inhibitory receptors as a potential treatment for enhancing the GVL effect after allo-HSCT without developing GVHD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.biosystems.2023.104889 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Regulatory Immune Cell-derived Exosomes: Modes of Action and Therapeutic Potential in Transplantation.
Transplantation
January 2025
Department of Surgery, Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh PA.
Reduced dependence on antirejection agents, improved long-term allograft survival, and induction of operational tolerance remain major unmet needs in organ transplantation due to the limitations of current immunosuppressive therapies. To address this challenge, investigators are exploring the therapeutic potential of adoptively transferred host- or donor-derived regulatory immune cells. Extracellular vesicles of endosomal origin (exosomes) secreted by these cells seem to be important contributors to their immunoregulatory properties.
View Article and Find Full Text PDFOocyte donation pregnancies with high fetal-maternal immunogenetic dissimilarity show alterations in the maternal peripheral immunoregulatory response.
J Reprod Immunol
December 2024
Department of Gynecology and Obstetrics, Leiden University Medical Center, the Netherlands.
Oocyte donation (OD) pregnancies result in increased fetal-maternal immunogenetic dissimilarity due to paternal and donor-derived genes. Higher fetal-maternal HLA mismatches are correlated with preeclampsia. Therefore, this study explored the maternal immune response, focusing on regulatory T cells (Tregs) during low versus high allogeneic pregnancies, and healthy versus preeclamptic OD pregnancies.
View Article and Find Full Text PDFDonor-derived infections-Insights from Singapore, Japan, and Thailand.
Transpl Infect Dis
November 2024
Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.
Article Synopsis
- Solid organ transplantation (SOT) in Asia has grown significantly, but donor-derived infections (DDIs) are a major concern as they can negatively affect transplant outcomes.
- A study was conducted by reaching out to transplant infectious diseases experts in Asia to gather standardized data on SOT numbers, DDI incidence, and screening protocols in countries like Singapore, Japan, and Thailand.
- The findings reveal that while mandatory screening for common infections like HIV and hepatitis is in place across the region, there is a notable lack of surveillance for DDIs, indicating an urgent need for a DDI registry and coordinated efforts to improve safety in organ transplantation.
Understanding and controlling the variables for stromal vascular fraction therapy.
World J Stem Cells
August 2024
Department of Regenerative Medicine, Mother Cell Regenerative Centre, Tiruchirappalli 620017, Tamil Nadu, India.
Article Synopsis
- The review focuses on the critical process of isolating mesenchymal stromal cells (MSCs) from the stromal vascular fraction (SVF) of adipose tissue, emphasizing factors like technique and immediate processing that affect cell functionality.
- It highlights the importance of fine-tuning enzymes during digestion, detailed filtration and centrifugation methods for purifying SVF, and assessing cell viability through techniques like flow cytometry.
- The conclusion calls for standardized protocols in MSC isolation to enhance reproducibility, along with ongoing research and collaboration to ensure patient safety and improve regenerative medicine outcomes.
Normothermic liver perfusion derived extracellular vesicles have concentration-dependent immunoregulatory properties.
J Extracell Vesicles
July 2024
Department of Surgery, Division of Transplantation, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Extracellular vesicles (EVs) are major contributors to immunological responses following solid organ transplantation. Donor derived EVs are best known for their role in transplant rejection through transferring donor major histocompatibility complex proteins to recipient antigen presenting cells, a phenomenon known as ‛cross-decoration'. In contrast, donor liver-derived EVs are associated with organ tolerance in small animal models.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!